PharmaTechFocus's profile picture. A digital magazine bringing you the latest trends and technologies in the industry. With daily news from Pharmaceutical Technology http://pharmaceutical-technology.com

Pharma Technology Focus

@PharmaTechFocus

A digital magazine bringing you the latest trends and technologies in the industry. With daily news from Pharmaceutical Technology http://pharmaceutical-technology.com

eschbach’s Shiftconnector®, which unifies real‑time plant data with role‑specific Tier Boards and embeds the SAMI AI assistant into daily workflows, has won this year’s Innovation and Product Launches Awards. Discover why: tinyurl.com/4pnnpskf #PharmaTech #ManufacturingAI

PharmaTechFocus's tweet image. eschbach’s Shiftconnector®, which unifies real‑time plant data with role‑specific Tier Boards and embeds the SAMI AI assistant into daily workflows, has won this year’s Innovation and Product Launches Awards.

Discover why: tinyurl.com/4pnnpskf

#PharmaTech #ManufacturingAI

Mural Health’s participant-first platform, which pairs high-touch personalised support with scalable payments and logistics tools, has won this year’s Innovation Award and Business Expansion Awards. Read more: tinyurl.com/mr2289t4 #HealthcareInnovation #DecentralisedTrials

PharmaTechFocus's tweet image. Mural Health’s participant-first platform, which pairs high-touch personalised support with scalable payments and logistics tools, has won this year’s Innovation Award and Business Expansion Awards.

Read more: tinyurl.com/mr2289t4

#HealthcareInnovation #DecentralisedTrials

RealTime eClinical Solutions' SOMS platform, which is streamlining site operations and accelerating trial timelines, has won this year's Innovation Award. RealTime also won the Marketing award for their strategic rebranding initiative. Read more: tinyurl.com/bdz7pytv

PharmaTechFocus's tweet image. RealTime eClinical Solutions' SOMS platform, which is streamlining site operations and accelerating trial timelines, has won this year's Innovation Award. RealTime also won the Marketing award for their strategic rebranding initiative.
Read more: tinyurl.com/bdz7pytv

AUTOMA+ 2025 (24-25 November, Vösendorf, Austria) gathers leading companies such as Takeda, Accord Healthcare, Sandoz, Novartis, Bayer AG, Novo Nordisk to explore digital innovative solutions for the pharmaceutical industry. Be a part of the Congress: sh.bgs.group/303

PharmaTechFocus's tweet image. AUTOMA+ 2025 (24-25 November, Vösendorf, Austria) gathers leading companies such as Takeda, Accord Healthcare, Sandoz, Novartis, Bayer AG, Novo Nordisk to explore digital innovative solutions for the pharmaceutical industry.

Be a part of the Congress: 
sh.bgs.group/303

We're pleased to announce our new media partnership with @AAPSComms PharmSci 360, in San Antonio this November. Join us and register today - lnkd.in/ef_qiw_i #PharmSci360

PharmaTechFocus's tweet image. We're pleased to announce our new media partnership with @AAPSComms PharmSci 360, in San Antonio this November. 

Join us and register today - lnkd.in/ef_qiw_i

#PharmSci360

i3 Membrane has been recognized with three prestigious honours at the 2025 Pharmaceutical Technology Excellence Awards, winning in the categories of Innovation, Research & Development, and Environmental. Find out more here - lnkd.in/g-6-tMbX

PharmaTechFocus's tweet image. i3 Membrane has been recognized with three prestigious honours at the 2025 Pharmaceutical Technology Excellence Awards, winning in the categories of Innovation, Research & Development, and Environmental.

Find out more here - lnkd.in/g-6-tMbX

The London Biotechnology Show 2025 is just around the corner! Meet 3,000+ industry leaders, explore 110+ cutting-edge exhibitors & discover the future of #biotech Visitor Passes are FREE – Register now → tinyurl.com/4vy8fnht #LifeSciences #Pharma #MedTech #HealthTech


TrialWire wins the Innovation Award at the 2025 Clinical Trials Arena Excellence Awards! Honoured for tackling patient enrollment challenges with AI-driven tools, risk-share models & rapid recruitment. Find out more - bit.ly/4dZocgA@

PharmaTechFocus's tweet image. TrialWire wins the Innovation Award at the 2025 Clinical Trials Arena Excellence Awards!

Honoured for tackling patient enrollment challenges with AI-driven tools, risk-share models & rapid recruitment.

Find out more - bit.ly/4dZocgA@

Congratulations to @novotechCRO who have been honoured in the 2025 Pharmaceutical Technology Excellence Awards across three major categories: Diversity, Research and Development, and Marketing. Find out more here - bit.ly/3F0J8Ha

PharmaTechFocus's tweet image. Congratulations to @novotechCRO who have been honoured in the 2025 Pharmaceutical Technology Excellence Awards across three major categories: Diversity, Research and Development, and Marketing.

Find out more here - bit.ly/3F0J8Ha

Celebrate 5 years of AUTOMA+! Join pharma leaders and digital experts in Vösendorf, Austria on 24-25 November 2025. Productive networking, various types of sessions, focus exhibition, gala dinner, grand lottery and more! Register: sh.bgs.group/2pn

PharmaTechFocus's tweet image. Celebrate 5 years of AUTOMA+! Join pharma leaders and digital experts in Vösendorf, Austria on 24-25 November 2025. Productive networking, various types of sessions, focus exhibition, gala dinner, grand lottery and more! 

Register: sh.bgs.group/2pn

Visitor Registration is Live! Join the UK’s leading biotech event to explore ground-breaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for free. Download your free pass at: tinyurl.com/mw4mzxt6


Alberta partners Siemens and the Alberta Cancer Foundation Siemens Healthineers will contribute $122m to establish two centres of excellence and further research initiatives. pharmaceutical-technology.com/news/alberta-s…

PharmaTechFocus's tweet image. Alberta partners Siemens and the Alberta Cancer Foundation

Siemens Healthineers will contribute $122m to establish two centres of excellence and further research initiatives.

 pharmaceutical-technology.com/news/alberta-s…

Augustine secures $85m to advance Charcot-Marie-Tooth candidate AGT-100216 will now enter a Phase I/II proof-of-concept clinical trial for CMT disease, with patient enrolment set to begin later this year. pharmaceutical-technology.com/news/augustine…

PharmaTechFocus's tweet image. Augustine secures $85m to advance Charcot-Marie-Tooth candidate

AGT-100216 will now enter a Phase I/II proof-of-concept clinical trial for CMT disease, with patient enrolment set to begin later this year.

 pharmaceutical-technology.com/news/augustine…

FDA approves IND application for Everest’s cancer vaccine The company completed subject dosing in an investigator-initiated trial of the vaccine in March 2025. pharmaceutical-technology.com/news/fda-evere…

PharmaTechFocus's tweet image. FDA approves IND application for Everest’s cancer vaccine

The company completed subject dosing in an investigator-initiated trial of the vaccine in March 2025.

 pharmaceutical-technology.com/news/fda-evere…

AstraZeneca to invest $2.5bn in R&D centre in China The new centre will focus on early-stage research and clinical development, supported by data science and AI labs. pharmaceutical-technology.com/news/astrazene…

PharmaTechFocus's tweet image. AstraZeneca to invest $2.5bn in R&D centre in China

The new centre will focus on early-stage research and clinical development, supported by data science and AI labs.

 pharmaceutical-technology.com/news/astrazene…

J&J boosts US operations with $55bn investment J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years. pharmaceutical-technology.com/news/jj-boosts…

PharmaTechFocus's tweet image. J&J boosts US operations with $55bn investment

J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.

 pharmaceutical-technology.com/news/jj-boosts…

Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug Amvuttra is now approved in the US to treat both cardiomyopathy and polyneuropathy manifestations of ATTR amyloidosis. pharmaceutical-technology.com/news/alnylam-c…

PharmaTechFocus's tweet image. Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug

Amvuttra is now approved in the US to treat both cardiomyopathy and polyneuropathy manifestations of ATTR amyloidosis.

 pharmaceutical-technology.com/news/alnylam-c…

Mastering compliance and copyright in healthcare and MedComms In the fast-paced world of medical communications, understanding reuse rights and copyright compliance is critical, particularly in today’s ever-evolving technological landscape. pharmaceutical-technology.com/sponsored/mast…

PharmaTechFocus's tweet image. Mastering compliance and copyright in healthcare and MedComms

In the fast-paced world of medical communications, understanding reuse rights and copyright compliance is critical, particularly in today’s ever-evolving technological landscape. 

 pharmaceutical-technology.com/sponsored/mast…

Loading...

Something went wrong.


Something went wrong.